Home » Pharma News (page 15)

Pharma News

Siemens, BioNTech to develop new personalized cancer vaccines

Siemens, BioNTech to develop new personalized cancer vaccines Siemens has entered into a strategic collaboration with BioNTech for the good manufacturing practice (GMP) production of personalized cancer vaccines. Under the deal, BioNTech’s subsidiaries, BioNTech RNA Pharmaceuticals and EUFETS, will work with Siemens to build a fully automated and digitalized production site to provide capacity for BioNTech’s personalized cancer vaccines to ... Read More »

AbCheck and Pierre Fabre Enter Into Strategic Research Partnership

AbCheck and Pierre Fabre Enter Into Strategic Research Partnership  AbCheck s.r.o, a wholly owned subsidiary of Affimed N.V., Heidelberg, Germany, and Pierre Fabre Pharmaceuticals have expanded their ongoing collaboration into a strategic research partnership in the field of human antibody discovery and optimization. Under the expanded agreement, AbCheck will use its proprietary human antibody discovery and optimization platform technologies, AbSieve ... Read More »

SPARC licenses Xelpros to Sun Pharma for US market

SPARC licenses Xelpros to Sun Pharma for US market Sun Pharma Advanced Research Company (SPARC) has licensed out Xelpros, a preservative-free eye drop, to a subsidiary of Sun Pharma for the US market. In addition to up-front payment of USD 3 million, SPARCBSE 2.83 % will receive certain other milestone payments, both totaling to USD 16 million from Sun Pharma, ... Read More »

Cipla’s Stempeutics gets process patent for Stempeucel from Japan

Cipla’s Stempeutics gets process patent for Stempeucel from Japan Drug major Cipla today said its JV firm Stempeutics Research has received process patent from the Japan Patent Office for novel stem cell drug Stempeucel aimed at treatment of critical limb ischemia (CLI). Stempeutics chief operating officer B N Manohar said: “The new patent strengthens our position in Japan, which have ... Read More »

Enter Sun Pharma for long term

Enter Sun Pharma for long term, says Sandeep Shenoy Sandeep Shenoy of Pioneer Investcorp told CNBC-TV18, ” Sun Pharmaceutical Industries  is a well-run company where the business models are not impeded, I don’t think the glitches make much of a problem on their business model. Any leader of a sector where there is a small stumble and you get a ... Read More »

Lupin submits fresh studies for two products suspended by EMA

Lupin submits fresh studies for two products suspended by EMA Drug firm LupinBSE 0.01 % has submitted fresh studies to the European Medicines Agency (EMA) for two products, which are among 700 generic drugs suspended by the health regulator due to flawed clinical trial data provided by GVK Bio. “The company has successfully conducted the new bio equivalence (BE) studies ... Read More »

Natco Pharma rallies on strong Q4FY15 results

Natco Pharma rallies on strong Q4FY15 results MUMBAI: Shares of midcap Natco Pharma surged over 4 per cent in early trade on the back of strong results for quarter ended March 2015. The company’s net profit surged 126.66 per cent in Jan-March quarter to Rs 54.4 crore as compared to a net profit of Rs 24 crore in the corresponding ... Read More »

Three new diabetes drugs come under the scanner of US drug regulator

Three new diabetes drugs come under the scanner of US drug regulator  Three new type-2 diabetes medicines, two of which were recently launched in India, have come under the scanner of the US drug regulator for potential risk of causing acidosis that could require hospitalization. The US Food and Drug Administration (FDA) has warned medical professionals and patients that type-2 ... Read More »

US lawsuit puts generic drug imports from India under scanner

US lawsuit puts generic drug imports from India under scanner WASHINGTON: A US class action lawsuit accusing India’s Ranbaxy of large-scale deception on its generic drug applications puts a question mark on drug imports from India, the largest supplier of generic drugs to the US. The problem of lack of compliance with US Food and Drug Administration (FDA) guidance and ... Read More »

US pharma sector welcomes India’s intellectual property policy

US pharma sector welcomes India’s intellectual property policy The US pharma sector has welcomed India’s recent moves on intellectual property, including bringing out a draft policy and sustained engagement, while regretting the consistent barriers posed by the country’s pharma sector to US companies. Acknowledging the “measured and cautious approach” of India in responding to recent requests for compulsory licenses and ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes